14.01 USD
▼-0.54-3.71%
盘后 14.11 +0.71%
2026-11-19
市值
$983.66M
市盈率
9.66
EPS
1.37
股息率
—
52 周区间
6.70 – 21.24
成交量
1.29M
Beta
2.99
目标价
27.50
52W 低 6.7052W 高 21.24
价格走势
公司简介
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company’s lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-bind...